DRUGSTORE.COM - Die Wiedergeburt des Online Handels! - 500 Beiträge pro Seite
eröffnet am 11.01.02 21:58:01 von
neuester Beitrag 28.01.02 22:11:00 von
neuester Beitrag 28.01.02 22:11:00 von
Beiträge: 3
ID: 533.326
ID: 533.326
Aufrufe heute: 0
Gesamt: 472
Gesamt: 472
Aktive User: 0
Top-Diskussionen
Titel | letzter Beitrag | Aufrufe |
---|---|---|
vor 1 Stunde | 2509 | |
01.05.24, 18:36 | 1976 | |
vor 1 Stunde | 1729 | |
gestern 19:24 | 1294 | |
gestern 18:35 | 1085 | |
heute 13:39 | 1016 | |
vor 1 Stunde | 967 | |
vor 1 Stunde | 798 |
Meistdiskutierte Wertpapiere
Platz | vorher | Wertpapier | Kurs | Perf. % | Anzahl | ||
---|---|---|---|---|---|---|---|
1. | 1. | 18.001,60 | +0,59 | 240 | |||
2. | 2. | 168,20 | +0,08 | 87 | |||
3. | 3. | 9,7000 | +12,27 | 75 | |||
4. | 14. | 6,1400 | -1,35 | 69 | |||
5. | 11. | 0,1865 | 0,00 | 52 | |||
6. | 7. | 0,8750 | -12,50 | 47 | |||
7. | 12. | 0,1561 | +2,97 | 38 | |||
8. | 6. | 2.302,50 | 0,00 | 36 |
@Alle
Drugstore.com DSCM hat gemeldet, daß die company im Jahr 2003 profitabel sein wird. Aus meiner Sicht ist das ein Top-Wert, wenn man auf ein Comeback der Internet-Werte zocken möchte. Hier die NEWS im Original:
Drugstore.com Expects To Reach Profitability In 2003
BELLEVUE, Wash. -(Dow Jones)- Drugstore.com Inc. (DSCM) said sales rose 19% in the fourth quarter as its customer base grew, and the online drug retailer expects to report a profit, excluding some items, in 2003.
In a press release Monday, Drugstore.com said preliminary fourth quarter results indicate that the company could turn a profit on earnings before interest, taxes, depreciation and amortization at the close of 2003.
The company expects fourth quarter sales of about $43 million, up from $36.2 million a year ago.
In the year-ago fourth quarter, ended Dec. 31, 2001, the company lost $43.2 million, or 68 cents a share.
Two analysts surveyed by Thomson Financial/First Call have Drugstore.com`s fourth quarter loss at 28 cents a share.
The company said it increased its customer base in the fourth quarter by 225, 000, to about 2.4 million, and reduced its cash use to $9.7 million, ending the year with $79 million. This is sufficient cash to reach break-even, the company said.
Shares of Drugstore.com traded recently at $2.53, up 32 cents, or 14.5%, on Nasdaq volume of 514,700 shares. Average daily volume is 195,350 shares.
Company Web site: http://www.drugstore.com
Description of Business
Primary SIC Code: 7375
--------------------------------------------------------------------------------
The company is an online retail drugstore and information site for health, beauty, wellness, personal care, pharmacy products and health related information. the products of the company can be divided into five categories: health, beauty, wellness, personal care and pharmacy. health: includes first-aid, medical devices for home healthcare and other products related to the body`s health needs. beauty: includes cosmetics, fragrances and a variety of skin care products. wellness: includes vitamins, nutritional supplements, herbs, homeopathy and other natural products. personal care: includes products related to hair, body and eye care, shaving, oral hygiene and feminine needs. pharmacy: consists of prescription medication for chronic illnesses, such as blood pressure, osteoporosis and depression. the products are either shipped to the customers or can be picked up at any rite aid store in the united states or place orders through the web site.
GN
Drugstore.com DSCM hat gemeldet, daß die company im Jahr 2003 profitabel sein wird. Aus meiner Sicht ist das ein Top-Wert, wenn man auf ein Comeback der Internet-Werte zocken möchte. Hier die NEWS im Original:
Drugstore.com Expects To Reach Profitability In 2003
BELLEVUE, Wash. -(Dow Jones)- Drugstore.com Inc. (DSCM) said sales rose 19% in the fourth quarter as its customer base grew, and the online drug retailer expects to report a profit, excluding some items, in 2003.
In a press release Monday, Drugstore.com said preliminary fourth quarter results indicate that the company could turn a profit on earnings before interest, taxes, depreciation and amortization at the close of 2003.
The company expects fourth quarter sales of about $43 million, up from $36.2 million a year ago.
In the year-ago fourth quarter, ended Dec. 31, 2001, the company lost $43.2 million, or 68 cents a share.
Two analysts surveyed by Thomson Financial/First Call have Drugstore.com`s fourth quarter loss at 28 cents a share.
The company said it increased its customer base in the fourth quarter by 225, 000, to about 2.4 million, and reduced its cash use to $9.7 million, ending the year with $79 million. This is sufficient cash to reach break-even, the company said.
Shares of Drugstore.com traded recently at $2.53, up 32 cents, or 14.5%, on Nasdaq volume of 514,700 shares. Average daily volume is 195,350 shares.
Company Web site: http://www.drugstore.com
Description of Business
Primary SIC Code: 7375
--------------------------------------------------------------------------------
The company is an online retail drugstore and information site for health, beauty, wellness, personal care, pharmacy products and health related information. the products of the company can be divided into five categories: health, beauty, wellness, personal care and pharmacy. health: includes first-aid, medical devices for home healthcare and other products related to the body`s health needs. beauty: includes cosmetics, fragrances and a variety of skin care products. wellness: includes vitamins, nutritional supplements, herbs, homeopathy and other natural products. personal care: includes products related to hair, body and eye care, shaving, oral hygiene and feminine needs. pharmacy: consists of prescription medication for chronic illnesses, such as blood pressure, osteoporosis and depression. the products are either shipped to the customers or can be picked up at any rite aid store in the united states or place orders through the web site.
GN
still und heimlich 400 prozent in nicht mal 2 Monaten!aber der Zug scheint wohl abgefahren zu sein.da zahlt einer 4,1 Euro,das ist ein aufschlag auf Nasdaq-Kurs von von 48 cents!
GUcken die überhaupt auf den Nasdaq Kurs??
GUcken die überhaupt auf den Nasdaq Kurs??
DSCM
drugstore.com Inc. Continues Solid Growth Towards Profitability
BELLEVUE, Wash.--(BUSINESS WIRE)--Jan. 28, 2002--
-- Internet retailer drugstore.com(TM) fourth quarter revenues, gross margin and pro forma operating loss all exceed expectations --
Following the recent announcement that the company plans to be EBITDA positive in 2003, drugstore.com, inc. (NasdaqSCM), the leading online retailer in the health, beauty, wellness, personal care and pharmacy category, today announced fourth quarter and full year financial results.
"Our fourth quarter results demonstrate that we can be both a high growth retailer and drive significant operating improvements in many areas from increasing gross margin to reducing costs that benefit the bottom line," says Kal Raman, president and CEO of drugstore.com, inc. "In spite of the current economic environment we have delivered on our promises, quarter after quarter. We are very proud of our accomplishments thus far."
Net sales for the fiscal year 2001 reached $145.3 million, and reflects a $35.3 million or 32% increase over fiscal year 2000. Gross margin dollars for the year grew to $24.6 million or 16.9% of net sales, up $15.3 million from the prior year, and operating expenses before impairment and restructuring charges, amortization of intangible assets and amortization of stock-based compensation declined by $63.6 million or 39% from fiscal year 2000. Pro forma net loss for the fiscal year end 2001 (excluding impairment and restructuring charges, amortization of intangible assets, amortization of stock-based compensation, extraordinary gain and cumulative effect adjustment) was $68.6 million which represents a $74.5 million decline from fiscal year 2000. Pro forma net loss per share for the fiscal year 2001 was $1.04 versus $2.64 for the fiscal year end 2000. On a GAAP basis, the net loss for fiscal year 2001 was $282.8 million and reflects non-cash impairment and restructuring charges of $178 million, primarily associated with the write-down of the company`s intangible assets. The GAAP loss on a per share basis for the fiscal year ending 2001 was $4.28 versus $3.56 for the fiscal year ending 2000.
Fourth quarter net sales were an all time high of $43.5 million and represented a 20% increase over the fourth quarter of 2000. Average net revenue per order increased by $13 year over year and reached $67. Gross margin improved sequentially for the tenth consecutive quarter to 18.5%, and operating expenses before impairment and restructuring charges, amortization of intangible assets and amortization of stock-based compensation declined by 35% or $12.9 million year over year. On a pro forma basis, net loss for the quarter (excluding impairment and restructuring charges, amortization of intangible assets and stock based compensation) decreased to $14.7 million, which reflects a year-over-year loss reduction of $13.9 million. Pro forma net loss per share decreased to $0.22 from a loss of $0.45 in the fourth quarter of 2000. Net loss on a GAAP basis was $182.9 million in the fourth quarter and reflected non-cash impairment and restructuring of $163 million. On a per share basis, the GAAP net loss was $2.75 in fourth quarter of 2001 versus a loss of $0.68 in the fourth quarter of 2000.
In accordance with Statement of Financial Accounting Standards (SFAS) 121, the company deemed it necessary to perform an analysis of the value of their long-lived assets because of certain economic and market conditions, the sustained decline in the company`s stock price and further refinement of their long term financial plan. Based on the results of the analysis, the company recorded a non-cash impairment charge of $163 million. The primary component of the impairment charge was a write-down of the intangible assets recorded in connection with the Rite Aid and GNC strategic agreements that were executed in 1999. The value of these intangible assets was based on the company`s stock price at the time the strategic agreements were executed. Despite the impairment charge and the decline in market valuation, these strategic agreements remain significant contributors to the company`s operation.
Financial Highlights for Fiscal Year 2001 (all comparisons are made with prior year unless otherwise noted)
-- drugstore.com,inc. announced a plan to achieve positive EBITDA
in 2003, approximately one year earlier than previously
forecasted.
-- Net sales for the year grew by $35.3 million and reached
$145.3 million.
-- Gross profit dollars increased by 165% or $15.3 million.
-- Operating expenses (excluding impairment and restructuring
charges, amortization of intangible assets, amortization of
stock-based compensation, extraordinary gain and cumulative
effect adjustment) declined by 39% or $63.6 million.
-- Pharmacy sales were 54% of net sales for the year.
-- Annualized revenue per active customer approximated $150, and
represents a $50 increase from 2000 (active customer is
defined as a unique customer who made a purchase with in the
last twelve months)
-- Inventory turns reached an all time high of 23 in the fourth
quarter, and reflects a 28% improvement from the fourth
quarter of 2000.
-- Quarterly cash use was reduced for the seventh consecutive
quarter to $9.7 million, and over the last year, the company`s
quarterly cash use has declined by $7.4 million.
Outlook for First Quarter and Fiscal Year 2002
drugstore.com expects 2002 net sales of $200 million, a gross margin approximating 19% and an EBITDA loss excluding non-cash marketing of approximately $25 to $26 million. For the first quarter of 2002, the company expects net sales to approximate $40 million, a gross margin at or near 18%, and an operating loss before interest taxes and amortization approximating $17 million. The company will look to acquire 800,000 to 900,000 new customers in the fiscal year 2002, and 185,000 to 190,000 in the first quarter of the year.
About drugstore.com
drugstore.com (NasdaqSCM) is a leading online drugstore and information site offering A Very Healthy Way to Shop(TM) for health, beauty, wellness, personal care, and pharmacy products. The drugstore.com(TM) Web site provides a convenient, private, and informative shopping experience that encourages consumers to purchase products essential to healthy, everyday living. The drugstore.com Web store offers thousands of brand-name personal health care products at competitive prices; a full-service, licensed retail pharmacy; and a wealth of health-related information, buying guides, and other tools designed to help consumers make informed purchasing decisions.
drugstore.com has been awarded the Verified Internet Pharmacy Practice Sites (VIPPS) certification by the National Association of Boards of Pharmacy (NABP) as a fully licensed facility exercising the best safe pharmacy practices in compliance with federal and state laws and regulations. drugstore.com has also been rated the top Health category site by Forrester PowerRankings, which provides objective rankings of the leading eCommerce sites.
In addition to Amazon.com (Nasdaq:AMZN), drugstore.com also has strategic relationships with Rite Aid Corporation (NYSE, PSE: RAD) General Nutrition Companies, and WellPoint Health Networks (NYSE:WPT). drugstore.com and A Very Healthy Way to Shop are trademarks of drugstore.com, inc.
GN
drugstore.com Inc. Continues Solid Growth Towards Profitability
BELLEVUE, Wash.--(BUSINESS WIRE)--Jan. 28, 2002--
-- Internet retailer drugstore.com(TM) fourth quarter revenues, gross margin and pro forma operating loss all exceed expectations --
Following the recent announcement that the company plans to be EBITDA positive in 2003, drugstore.com, inc. (NasdaqSCM), the leading online retailer in the health, beauty, wellness, personal care and pharmacy category, today announced fourth quarter and full year financial results.
"Our fourth quarter results demonstrate that we can be both a high growth retailer and drive significant operating improvements in many areas from increasing gross margin to reducing costs that benefit the bottom line," says Kal Raman, president and CEO of drugstore.com, inc. "In spite of the current economic environment we have delivered on our promises, quarter after quarter. We are very proud of our accomplishments thus far."
Net sales for the fiscal year 2001 reached $145.3 million, and reflects a $35.3 million or 32% increase over fiscal year 2000. Gross margin dollars for the year grew to $24.6 million or 16.9% of net sales, up $15.3 million from the prior year, and operating expenses before impairment and restructuring charges, amortization of intangible assets and amortization of stock-based compensation declined by $63.6 million or 39% from fiscal year 2000. Pro forma net loss for the fiscal year end 2001 (excluding impairment and restructuring charges, amortization of intangible assets, amortization of stock-based compensation, extraordinary gain and cumulative effect adjustment) was $68.6 million which represents a $74.5 million decline from fiscal year 2000. Pro forma net loss per share for the fiscal year 2001 was $1.04 versus $2.64 for the fiscal year end 2000. On a GAAP basis, the net loss for fiscal year 2001 was $282.8 million and reflects non-cash impairment and restructuring charges of $178 million, primarily associated with the write-down of the company`s intangible assets. The GAAP loss on a per share basis for the fiscal year ending 2001 was $4.28 versus $3.56 for the fiscal year ending 2000.
Fourth quarter net sales were an all time high of $43.5 million and represented a 20% increase over the fourth quarter of 2000. Average net revenue per order increased by $13 year over year and reached $67. Gross margin improved sequentially for the tenth consecutive quarter to 18.5%, and operating expenses before impairment and restructuring charges, amortization of intangible assets and amortization of stock-based compensation declined by 35% or $12.9 million year over year. On a pro forma basis, net loss for the quarter (excluding impairment and restructuring charges, amortization of intangible assets and stock based compensation) decreased to $14.7 million, which reflects a year-over-year loss reduction of $13.9 million. Pro forma net loss per share decreased to $0.22 from a loss of $0.45 in the fourth quarter of 2000. Net loss on a GAAP basis was $182.9 million in the fourth quarter and reflected non-cash impairment and restructuring of $163 million. On a per share basis, the GAAP net loss was $2.75 in fourth quarter of 2001 versus a loss of $0.68 in the fourth quarter of 2000.
In accordance with Statement of Financial Accounting Standards (SFAS) 121, the company deemed it necessary to perform an analysis of the value of their long-lived assets because of certain economic and market conditions, the sustained decline in the company`s stock price and further refinement of their long term financial plan. Based on the results of the analysis, the company recorded a non-cash impairment charge of $163 million. The primary component of the impairment charge was a write-down of the intangible assets recorded in connection with the Rite Aid and GNC strategic agreements that were executed in 1999. The value of these intangible assets was based on the company`s stock price at the time the strategic agreements were executed. Despite the impairment charge and the decline in market valuation, these strategic agreements remain significant contributors to the company`s operation.
Financial Highlights for Fiscal Year 2001 (all comparisons are made with prior year unless otherwise noted)
-- drugstore.com,inc. announced a plan to achieve positive EBITDA
in 2003, approximately one year earlier than previously
forecasted.
-- Net sales for the year grew by $35.3 million and reached
$145.3 million.
-- Gross profit dollars increased by 165% or $15.3 million.
-- Operating expenses (excluding impairment and restructuring
charges, amortization of intangible assets, amortization of
stock-based compensation, extraordinary gain and cumulative
effect adjustment) declined by 39% or $63.6 million.
-- Pharmacy sales were 54% of net sales for the year.
-- Annualized revenue per active customer approximated $150, and
represents a $50 increase from 2000 (active customer is
defined as a unique customer who made a purchase with in the
last twelve months)
-- Inventory turns reached an all time high of 23 in the fourth
quarter, and reflects a 28% improvement from the fourth
quarter of 2000.
-- Quarterly cash use was reduced for the seventh consecutive
quarter to $9.7 million, and over the last year, the company`s
quarterly cash use has declined by $7.4 million.
Outlook for First Quarter and Fiscal Year 2002
drugstore.com expects 2002 net sales of $200 million, a gross margin approximating 19% and an EBITDA loss excluding non-cash marketing of approximately $25 to $26 million. For the first quarter of 2002, the company expects net sales to approximate $40 million, a gross margin at or near 18%, and an operating loss before interest taxes and amortization approximating $17 million. The company will look to acquire 800,000 to 900,000 new customers in the fiscal year 2002, and 185,000 to 190,000 in the first quarter of the year.
About drugstore.com
drugstore.com (NasdaqSCM) is a leading online drugstore and information site offering A Very Healthy Way to Shop(TM) for health, beauty, wellness, personal care, and pharmacy products. The drugstore.com(TM) Web site provides a convenient, private, and informative shopping experience that encourages consumers to purchase products essential to healthy, everyday living. The drugstore.com Web store offers thousands of brand-name personal health care products at competitive prices; a full-service, licensed retail pharmacy; and a wealth of health-related information, buying guides, and other tools designed to help consumers make informed purchasing decisions.
drugstore.com has been awarded the Verified Internet Pharmacy Practice Sites (VIPPS) certification by the National Association of Boards of Pharmacy (NABP) as a fully licensed facility exercising the best safe pharmacy practices in compliance with federal and state laws and regulations. drugstore.com has also been rated the top Health category site by Forrester PowerRankings, which provides objective rankings of the leading eCommerce sites.
In addition to Amazon.com (Nasdaq:AMZN), drugstore.com also has strategic relationships with Rite Aid Corporation (NYSE, PSE: RAD) General Nutrition Companies, and WellPoint Health Networks (NYSE:WPT). drugstore.com and A Very Healthy Way to Shop are trademarks of drugstore.com, inc.
GN
Beitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
Wertpapier | Beiträge | |
---|---|---|
104 | ||
74 | ||
71 | ||
52 | ||
42 | ||
30 | ||
23 | ||
22 | ||
21 | ||
19 |
Wertpapier | Beiträge | |
---|---|---|
18 | ||
15 | ||
15 | ||
13 | ||
13 | ||
13 | ||
13 | ||
13 | ||
12 | ||
12 |